Search Results - "Oymak, E."

Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease by Onal, C., Oymak, E., Guler, O.C.

Get full text

Long-term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response by Onal, C., Oymak, E., Guler, O.C.

Get full text

80PD PROGNOSTIC IMPORTANCE OF GROSS TUMOR VOLUME DEFINED BY UTILIZING 18-FDG-PET/CT IN STAGE IIIB NON-SMALL CELL LUNG CARCINOMA TREATED WITH DEFINITIVE CHEMORADIOTHERAPY by Parlak, C, Pehlivan, B, Oymak, E, Topuk, S, Topkan, E

Get full text

PO-1862 Revisiting whole brain radiotherapy standards: Is it time to abandon opposed lateral fields? by Oymak, E., Polat, M.

Get full text

PO-1472 The Dosimetric Analysis & Clinical Outcomes of Contiguous Vertebrae SBRT in Oligometastatic Patients by Guler, O.C., Oymak, E., Onal, C.

Get full text

Treatment Outcomes of Simultaneous Integrated Boost to Intraprostatic Lesions with External Beam Radiotherapy in Localized Prostate Cancer Patients by Onal, H.C., Erbay, G., Guler, O.C., Yavas, C., Oymak, E.

“…To evaluate the treatment outcomes and toxicity of definitive radiotherapy (RT) for prostate cancer (PC) patients using the simultaneous integrated boost (SIB)…”
Get full text

PO-1281 The prognostic significance of the albumin and globulin levels in cervical cancer patients by Onal, C., Oymak, E., Guler, O.C.

Get full text

PD-0728 Significance of liver metastasis volume in breast cancer treated with stereotactic body radiotherapy by Oymak, E., Güler, O.C., Önal, C.

Get full text

PO-1449 The effect of ADT on ADC change in intermediate-risk prostate cancer patients receiving radiotherapy by Onal, C., Erbay, G., Oymak, E., Guler, O.C.

Get full text

MO-0869 The impact of the ADC for the early prediction of treatment response after definitive radiotherapy by Onal, C., Erbay, G., Guler, O.C., Oymak, E.

Get full text

PO-1380 Response evaluation with 68GA-PSMA-PET/CT in prostate cancer patients treated with radiotherapy by Onal, C., Guler, O., Oymak, E., Torun, N., Reyhan, M.

Get full text

PO-1468 Radiotherapy journey to peripheral centers in Turkey: How far is close enough? by Oymak, E., Şahin, C., Akpınar Palabıyık, Z., Önal, C.

Get full text

The Outcomes of Definitive Radiotherapy in Patients with Prostate Cancer Using Simultaneous Integrated Boost Technique by Onal, C., Guler, O.C., Erbay, G., Oymak, E., Yavas, C., Yavas, G.

Get full text

The Effect of the Time Interval between Temozolomide and Radiotherapy in Adjuvant High-Grade Glioma Treatment by Oymak, E., Demircan, V., Şenyürek, Ş., Yavas, G., Guler, O.C., Bolukbasi, Y., Erpolat, P., Onal, C.

Get full text

Bone Only Oligometastatic Renal Cell Carcinoma Patients Treated with Stereotactic Body Radiotherapy: A MULTI-Institutional Study by Onal, C., Guler, O.C., Hürmüz, P., Yavas, G., Tilki, B., Oymak, E., Yavas, C., Ozyigit, G.

Get full text

The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy by Onal, C., Erbay, G., Guler, O.C., Oymak, E., Yavas, C., Yavas, G.

Get full text

PO-1547 SBRT and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma by Onal, C., Oymak, E., Guler, O.C., Tilki, B., Yavas, G., Hurmuz, P., Yavas, C., Ozyigit, G.

Get full text

Stereotactic Radiotherapy to Oligoprogressive Lesions Detected With 68Ga-PSMA-PET/CT in Castration-Resistant Prostate Cancer Patients by Onal, C., Ozyigit, G., Oymak, E., Guler, O.C., Tilki, B., Hurmuz, P., Akyol, F.

“…Few studies have investigated the feasibility of MDT in metastatic castration-resistant prostate cancer (CRPC) patients with heterogeneous patient populations…”
Get full text

8044 Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer for target volume coverage and organs at risk doses by Onal, C, Arslan, G, Topkan, E, Yavuz, M, Oymak, E, Yavuz, A

Get full text

PH-0446 The impact of lymph node ratio in patients with stage IIIC endometrial carcinoma by Onal, C., Yuce Sari, S., Yavas, G., Guler, O.C., Yigit, E., Oymak, E., Gultekin, M., Yildiz, F.

Get full text